ShockWave Medical, Inc. (SWAV)

NASDAQ: SWAV · Delayed Price · USD
134.67
-6.07 (-4.31%)
At close: Jan 21, 2022 4:00 PM
134.77
0.10 (0.07%)
After-hours:Jan 21, 2022 6:35 PM EST
Market Cap4.75B
Revenue (ttm)175.68M
Net Income (ttm)-37.95M
Shares Out35.30M
EPS (ttm)-1.09
PE Ration/a
Forward PE106.38
Dividendn/a
Ex-Dividend Daten/a
Volume568,831
Open136.57
Previous Close140.74
Day's Range133.01 - 140.19
52-Week Range91.47 - 249.73
Beta1.26
AnalystsBuy
Price Target248.00 (+84.2%)
Earnings DateFeb 17, 2022

About SWAV

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists ...

IndustryHealth Care Equipment & Supplies
IPO DateMar 7, 2019
CEODouglas Godshall
Employees449
Stock ExchangeNASDAQ
Ticker SymbolSWAV
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for SWAV stock is "Buy." The 12-month stock price forecast is 248.00, which is an increase of 84.15% from the latest price.

Price Target
$248.00
(84.15% upside)
Analyst Consensus: Buy

News

Here's Why ShockWave Medical Stock Is Perking Up This Week

Buyout rumors have been swirling around this mid-cap medtech company this week.

1 week ago - The Motley Fool

Strength Seen in Shockwave Medical (SWAV): Can Its 4.5% Jump Turn into More Strength?

Shockwave Medical (SWAV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incr...

1 week ago - Zacks Investment Research

Penumbra Weighing Combination With Shockwave Medical: Bloomberg

Penumbra Inc (NYSE: PEN) is exploring a potential deal with Shockwave Medical Inc (NASDAQ: SWAV), Bloomberg reported citing people with knowledge of the matter. According to the people, Penumbra has hel...

Other symbols:PEN
1 week ago - Benzinga

Shockwave Medical Provides Quarterly Earnings Release Dates for 2022

SANTA CLARA, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calc...

2 weeks ago - GlobeNewsWire

Shockwave Medical Enrolls First Patient in Disrupt BTK II Study for Long, Calcified, Below the Knee Lesions

Global Post-Market Study Will Assess Long-Term Benefit of Peripheral IVL on the Most Challenging Calcified Lesions, Including Patients with Critical Limb Ischemia Global Post-Market Study Will Assess Lo...

1 month ago - GlobeNewsWire

Shockwave Medical to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

SANTA CLARA, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular d...

2 months ago - GlobeNewsWire

Shockwave Medical (SWAV) Gains 0.6% Post Q3 Earnings Beat

Shockwave Medical's (SWAV) third-quarter results reflect robust revenue growth and expansion in gross margin.

2 months ago - Zacks Investment Research

Shockwave Medical (SWAV) Q3 Earnings and Revenues Surpass Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 171.43% and 5.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

ShockWave Medical: Q3 Earnings Insights

ShockWave Medical (NASDAQ:SWAV) reported its Q3 earnings results on Monday, November 8, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

2 months ago - Benzinga

Shockwave Medical Reports Third Quarter 2021 Financial Results

SANTA CLARA, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calc...

2 months ago - GlobeNewsWire

Earnings Outlook For ShockWave Medical

ShockWave Medical (NASDAQ:SWAV) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement.

2 months ago - Benzinga

Shockwave Medical Unveils First One-Year Results of Coronary Intravascular Lithotripsy

New Data at TCT From the Disrupt CAD Clinical Program Demonstrate Consistency of Shockwave IVL Outcomes Over Time, Across Calcium Morphologies and Between Genders New Data at TCT From the Disrupt CAD Cl...

2 months ago - GlobeNewsWire

Centers For Medicare & Medicaid Services Increases Hospital Outpatient Payment for Peripheral Intravascular Lithotripsy

Above the Knee Peripheral IVL APC Assignments Increased in CY 2022 Final Hospital Outpatient Rule Above the Knee Peripheral IVL APC Assignments Increased in CY 2022 Final Hospital Outpatient Rule

2 months ago - GlobeNewsWire

Will Shockwave Medical (SWAV) Report Negative Earnings Next Week? What You Should Know

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

ShockWave Medical (SWAV) Sees Hammer Chart Pattern: Time to Buy?

ShockWave Medical (SWAV) has been struggling lately, but the selling pressure may be coming to an end soon.

3 months ago - Zacks Investment Research

Shockwave IVL Consistently Treats “Real World” Calcium Across Multiple Peripheral Vessel Beds

Disrupt PAD III Observational Arm Confirms IVL Safely and Effectively Modifies Superficial and Deep Calcium in Complex Calcified Lesions Disrupt PAD III Observational Arm Confirms IVL Safely and Effecti...

3 months ago - GlobeNewsWire

Shockwave Medical to Report Third Quarter 2021 Financial Results on November 8, 2021

SANTA CLARA, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calc...

3 months ago - GlobeNewsWire

Shockwave Medical Insider Trades $877 Thousand In Company Stock

Frank T Watkins, Director at Shockwave Medical (NASDAQ:SWAV), made a large insider sell on September 22, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchan...

3 months ago - Benzinga

Why Did Shockwave Medical Stock Gain 18% in August?

The medical device stock is growing even quicker than investors anticipated.

4 months ago - The Motley Fool

Shockwave Medical to Participate in Two Upcoming Virtual Investor Conferences

SANTA CLARA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular ...

4 months ago - GlobeNewsWire

This Healthcare Stock Grew Revenue by More Than 400% in the Second Quarter

Here's one innovative company you might want to put on your radar.

4 months ago - The Motley Fool

ShockWave Medical (SWAV) Q2 Earnings, Revenues Top Estimates

ShockWave Medical's (SWAV) robust performance across product lines and geographies drive its Q2 sales.

5 months ago - Zacks Investment Research

Why Shockwave Medical Surged as High as 10% Today

Top- and bottom-line beats plus raised guidance made for a very healthy stock on Monday.

5 months ago - The Motley Fool

Shockwave Medical Reports Narrower Than Expected Q2 Loss; Guides Above Consensus

Shockwave Medical Inc's (NASDAQ: SWAV) second-quarter FY21 sales were up 4-fold to $55.9 million beating the Wall Street consensus of $45.17 million. The growth was primarily driven by the launch of the...

5 months ago - Benzinga

Shockwave Medical (SWAV) Reports Q2 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 97.56% and 28.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research